Günther Staffler
Chief Tech/Sci/R&D Officer at AFFiRiS AG
Profile
Günther Staffler is currently the Chief Technology Officer at AFFiRiS AG since 2009.
Prior to this, he worked as a Lecturer at the University of Vienna from 1997 to 2001 and as the Head-Preclinical Development at Biovertis AG from 2003 to 2007.
He completed his undergraduate degree at the University of Vienna.
Günther Staffler active positions
| Companies | Position | Start |
|---|---|---|
AFFiRiS AG
 AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | Chief Tech/Sci/R&D Officer | 2007-02-28 |
Former positions of Günther Staffler
| Companies | Position | End |
|---|---|---|
Biovertis AG
 Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | 2006-12-31 |
| University of Vienna | Corporate Officer/Principal | 2000-12-31 |
Training of Günther Staffler
| University of Vienna | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | Health Services |
Biovertis AG
Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | Health Technology |
- Stock Market
- Insiders
- Günther Staffler
